H.I.G. Capital News
Quinnova Pharmaceuticals, Inc.
411 South State Street, 3rd Floor
Newtown, PA 18940
Quinnova Pharmaceuticals, Inc. Announces the Launch of Neosalus® Lotion
New product completes family of topical that aid skin disorders and promote healthy skin
NEWTOWN, PA - November 7, 2011 - Quinnova Pharmaceuticals, Inc. announces the launch of Neosalus® Lotion, the newest addition to its Neosalus® line. Neosalus® Lotion is a non---steroidal anti-inflammatory prescription product that offers topical treatment for the management of skin disorders, including atopic dermatitis and allergic contact dermatitis.
Neosalus® Lotion, along with Neosalus® Foam and Neosalus® Cream, uses Patented Proderm Technology® to help provide skin barrier repair, protection, and hydration. In addition, the Neosalus® line of products Is specially formulated with several key ingredients that can promote healthy skin: dimethicone to help restore the skin barrier and reduce trans---epidermal water loss (TEWL); glycerin, a humectants to help retain moisture; and stearic/palmitic acids to produce ceramides, cholesterol, and other free fatty acids in the ratio the skin needs.
All Neosalus® products are non---comedogenic and petrolatum---free and do not contain steroids or alcohol. Multiple dosage forms offer several convenient options to meet patients’ site---specific needs - Neosalus® Cream can be used to treat problem dry skin on the hands, face, and elbows; Neosalus® Foam is suited for hair---bearing skin on the chest, arms, and legs; and the new Neosalus® Lotion may be used for total body coverage, Including the face.
The U.S. therapeutic dermatology market, which focuses on disorders and diseases of the skin, mucous membrane, hair and nails, is expected to reach $8.9 billion by 2013 due to the often chronic nature of these diseases.
About Quinnova Pharmaceuticals, Inc.
A wholly owned subsidiary of AmDerma, LLC, Quinnova Pharmaceuticals, Inc. is a specialty pharmaceutical Company founded on innovative, patent---protected dermal delivery technologies.
Our delivery platforms are utilized to transport safe and effective pharmaceutical ingredients through the epidermis in unique, convenient, and cosmetically elegant formulations. Addressing a wide variety of skin conditions, it is our mission to provide superior treatment solutions and product value to clinicians and patients alike. For more information, please visit www.quinnova.com.